Page 9 - CUA 2020_Endourology
P. 9

Unmoderated Posters 1: Prostate Cancer, Endourology, BPH





        increased significantly with the second update. The impact of USPSTF   UP-1.13. Table 1. Targeted biopsy results for 46 patients
        recommendations on prostate cancer severity and age at diagnosis should   receiving targeted transperineal biopsies
        be examined in further studies, as well as exploring the pathologic details
        after treatment and longer-term outcomes.                                           First target   Second
        References                                                                            (n=46)  target (n=6)
        1.   U.S. Preventive Services Task Force. Final recommendation state-  Number of cores taken within target  2 (1–2)  1 (1–2)
            ment: Prostate cancer: Screening. October 2018.
        2.   Fleshner K, Carlsson SV, Roobol MJ. The effect of the USPSTF PSA   Number of targeted cores positive  1 (1–2)  1 (0–1)
            screening recommendation on prostate cancer incidence patterns   Percentage of biopsy tissue positive   35 (5–60)  5 (0–50)
            in the USA. Nat Rev Urol 2017;14:26-37. https://doi.org/10.1038/  (%)
            nrurol.2016.251                                    Grade group of targeted biopsies
                                                                0                            11 (24%)  2 (33%)
        UP-1.12                                                 1                            17 (37%)  2 (33%)
        North American urology resident perspectives on their exposure,
        experience, and ability to interpret multiparametric magnetic   2                    17 (37%)  2 (33%)
        resonance imaging of the prostate using PI-RADS V2      3                             1 (2%)   0 (0%)
        Kashif Visram , D. Robert Siemens , Craig Rodrigues  1  *Values are the median (interquartile range) or number (%).
                 1
                                1
        1 Urology, Queen’s University, Kingston, ON, Canada
        Introduction: Multiparametric magnetic resonance imaging (mpMRI) of
        the prostate with PI-RADS V2 grading is a tool recently introduced into   were included in this study. A Youden cutpoint was used to determine the
        the armamentarium of urologists for identifying localized prostate cancer.   eA in the axial plan (perpendicular to the plane of biopsy) best predicting
        Despite high uptake in use, there exist knowledge gaps in the urologist’s   for ≥GG 2 disease within the TBx cores. Logistic regression, including
        ability to interpret these. Our objective was to obtain the perspective of   PIRADS score, nodule location, and number of TBx cores, was then used
        North American residents on their comfort with mpMRI and PI-RADS V2   to determine predictive power of the cutpoint.
        grading to determine whether there is a need to develop learning tools.   Results: Median time from MR imaging to TBx was 2.4 (1.4–5.5) months.
        Methods: A survey was created to obtain information about exposure,   Forty of 46 (87%) patients had one nodule and six of 46 (13%) had two
        experience, and comfort with interpretation of mpMRI. This survey was   separate nodules on MR that received TBx. Of the 52 nodules, five (10%),
        completed by all chief residents that attended the QUEST urology course   33 (63%), and 14 (27%) were PIRADS 3, 4, and 5, respectively. Thirteen
        in Kingston and residents that attended the Upstate New York Urological   (25%), six (12%), and 33 (64%) were in the anterior, medial, and posterior
                                                                                                              2
        Association resident research meeting. Demographic information, as well   regions of the prostate, respectively. Median eA was 0.72 (0.49–1.29) cm
        as Likert scale questions (1, strongly disagree to 5, strongly agree) were   (average diameter 9.5 mm). TBx results are presented in Table 1. Fifteen
        obtained to capture respondent perspectives.         of 46 (33%) patients had ≥1 RBx core and 20/52 (38%) nodules had ≥1
                                                                                                              2
        Results: Fifty-three surveys were completed by PGY-1 to PGY-5 residents,   TBx revealing ≥GG 2 disease. The optimal eA cutpoint was ≥0.7 cm ,
        with 35 being PGY-5. Of these, only 12 had received formal training in   with an area under the curve (AUC) of 0.671 (0.510–0.832). Sixteen of
                                                                                      2
        mpMRI interpretation via course or lecture. Forty-eight of these residents   28 (57%) nodules with eA ≥0.7 cm  and four of 24 (17%) nodules with
                                                                      2
        had performed prostate biopsies and 43 had thoroughly reviewed mpM-  eA <0.7 cm  harbored ≥GG 2 disease (Fisher’s p=0.004). On logistic
                                                                              2
        RIs. Residents disagreed with understanding the components of PI-RADS   regression, eA ≥0.7 cm  was solely predictive of TBx revealing ≥GG 2
        V2 scoring for T2W films (2.45±1.01), DWI films (2.26±0.90), and DCE   disease (hazard ratio 6.5 [1.3–32.4]; p=0.022).
                                                                                      2
        films (2.21± 0.99) and their ability to interpret T2W films (2.43±1.06) and   Conclusions: Having an eA ≥0.7cm  may predict for transperineal-based
        DCE films (2.92±1.11). They felt neutral towards interpreting DCE films   TBx being positive for ≥GG 2 disease when 1–2 cores are taken.
        (3.08±1.30). Residents agreed that they are interested in learning opportu-  References
        nities to enhance their ability to interpret mpMRI films (4.21±0.91). They   1.   Stefanova V, Buckley R, Flax S, et al. Transperineal prostate biop-
        suggested lectures and online modules as preferred modalities.  sies under local anesthetic: Experience with 1287 patients prostate
        Conclusions: mpMRI is becoming more frequently used in urology to   cancer detection rate, complications, and patient tolerability. J Urol
        diagnose localized prostate cancer. However, residents feel that their   2019;201:1121-6. https://doi.org/10.1097/JU.0000000000000156
        ability to interpret these images is not optimal. To improve this, there is   2.   Klotz L, Pond G, Loblaw A, et al. Randomized study of systematic
        interest in tools that could help develop these skills. Online modules and   biopsy vs. magnetic resonance imaging and targeted and system-
        lectures were suggested options for this.                atic biopsy in men on active surveillance (ASIST): 2-year post-
                                                                 biopsy followup. Eur Urol 2019;10:007. https://doi.org/10.1016/j.
                                                                 eururo.2019.10.007
        UP-1.13
        Results of magnetic resonance-targeted transperineal biopsy in   UP-1.14
        patients with grade group 1 prostate cancer
        Kevin Martell , Hans Chung , Gerard Morton , Danny Vesprini , Eric   Utility of magnetic resonance imaging-targeted biopsy in
                                                      1
                             1
                                         1
                  1,2
        Tseng , Ewa Szumacher , Patrick Cheung , Will Chu , Stanley Liu , Andrew   predicting post-radical prostatectomy NCCN risk stratification
                                           1
                                    1
                        1
                                                   1
            1
                                                                       1
                                                                                                        1
                                                                                      1
        Loblaw 1                                             Kevin Hanna , Amber McMahon , Richard L Sleightholm , Bryant
                                                                                   1
                                                                      1
        1 Radiation  Oncology,  University  of  Toronto,  Toronto,  ON,   VanLeeuwen , Shawna L. Boyle
                                                             1
        Canada;  Oncology, University of Calgary, Calgary, AB, Canada  Department of Surgery, Division of Urologic Surgery, University of
              2
        Introduction: With increased use of magnetic resonance (MR) imaging in   Nebraska Medical Center, Omaha, NE, United States
        patients on active surveillance for prostate cancer, targeted biopsies (TBx)   Introduction: Accurate grading and staging of prostate cancer is para-
        of MR nodule(s) at the time of restaging biopsy is becoming common-  mount in guiding treatment for men with prostate cancer. Historically,
        place.  This study described a cohort of patients on active surveillance   there has been significant heterogeneity in NCCN risk stratification from
            1,2
                                                                                             1
        for grade group (GG) 1 disease who had MR imaging and then TBx of   initial biopsy to post-radical prostatectomy (RP).  In recent years, magnetic
        the nodule(s) found. It aimed to determine the minimum nodule cross-  resonance imaging (MRI)-targeted biopsy has emerged as an improved
        sectional ellipsoid area on MR (eA) that best predicts for TBx revealing   means of detecting prostate cancer compared to systematic transrectal
                                                                                         2
        GG2 or higher disease.                               ultrasonography-guided biopsy (TRUS).  We seek to determine if MRI-
        Methods: Forty-six patients receiving cognitively fused, MR-guided, trans-  targeted biopsy more accurately grades prostate cancer compared to
        perineal TBx alongside six random biopsies (RBx) between 2015 and 2019   systematic TRUS.
                                                CUAJ • June 2020 • Volume 14, Issue 6(Suppl2)                S47
   4   5   6   7   8   9   10   11   12   13   14